Known targets — ChEMBL curated mechanism
ADORA1ADORA2AADORA2BADORA3PDE3APDE3BPDE4APDE4BPDE4CPDE4D
The experimentally established mechanism targets of Cysteine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 1/20 | 0.80 |
| ▸ | SLC7A11 | Q9UPY5 | 1/20 | 0.80 |
| ▸ | GLRA1 | P23415 | 1/20 | 0.50 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.50 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.50 |
| ▸ | GSR | P00390 | 2/20 | 0.46 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.46 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.46 |
| ▸ | GRM1 | Q13255 | 2/20 | 0.46 |
| ▸ | GRM2 | Q14416 | 2/20 | 0.46 |
| ▸ | GRM8 | O00222 | 1/20 | 0.46 |
| ▸ | GRM6 | O15303 | 1/20 | 0.46 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.46 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | GRM5 | P41594 | 1/20 | 0.46 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.46 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.46 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.46 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cysteine SCHEMBL902046 | 1.00 | PTGS1 (0.80) | PTGS1SLC7A11GLRA1SLC6A9OR51E2 | |
| Cysteine SCHEMBL3320713 | 1.00 | PTGS1 (0.80) | PTGS1SLC7A11GLRA1SLC6A9OR51E2 | |
| Cysteine SCHEMBL6675043 | 1.00 | PTGS1 (0.80) | PTGS1SLC7A11GLRA1SLC6A9OR51E2 | |
| Cysteine SCHEMBL2233580 | 1.00 | PTGS1 (0.80) | PTGS1SLC7A11GLRA1SLC6A9OR51E2 | |
| Cysteine SCHEMBL3320717 | 1.00 | PTGS1 (0.80) | PTGS1SLC7A11GLRA1SLC6A9OR51E2 | |
| Cysteine SCHEMBL6028716 | 1.00 | PTGS1 (0.80) | PTGS1SLC7A11GLRA1SLC6A9OR51E2 | |
| Cysteine SCHEMBL1907826 | 1.00 | PTGS1 (0.80) | PTGS1SLC7A11GLRA1SLC6A9OR51E2 | |
| Cysteine SCHEMBL28436580 | 0.98 | PTGS1 (0.76) | PTGS1SLC7A11GLRA1SLC6A9OR51E2 | |
| Aspartic Acid SCHEMBL8628354 | 0.91 | PTGS1 (0.67) | PTGS1SLC7A11GLRA1SLC6A9OR51E2 | |
| Serine SCHEMBL418635 | 0.91 | PTGS1 (0.67) | PTGS1SLC7A11GLRA1SLC6A9OR51E2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 120 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117405800-A | Method for simultaneously detecting reduced biological ammonia sulfhydryl compound and oxidized biological ammonia sulfhydryl compound | 上海中医药大学 | 2024-01-16 | — | — | CN | claimed |
| CN-106906198-A | Cellulase for improving temperature resistance | 东莞泛亚太生物科技有限公司 | 2017-06-30 | — | — | CN | claimed |
| CN-104172194-A | FOOD COMPOSITION FOR BINDING ACETALDEHYDE IN MOUTH AND IN DIGESTIVE TRACK, AND METHOD FOR THE PREPARATION OF THE COMPOSITION | BIOHIT OY J | 2014-12-03 | — | — | CN | claimed |
| US-8758812-B2 | Composition for foodstuff for binding acetaldehyde | BIOHIT OYJ (FI) | 2014-06-24 | — | — | US | claimed |
| WO-2013001167-A1 | NON-TOXIC COMPOSITIONS FOR DECREASING THE RISK OF CANCER CAUSED BY ORAL MICROBES | BIOHIT OYJ (FI) | 2013-01-03 | — | — | WO | claimed |
| US-8227513-B2 | Food composition for binding acetaldehyde in mouth and in digestive track, and method for the preparation of the composition | BIOHIT OYJ (FI) | 2012-07-24 | — | — | US | claimed |
| US-20110171296-A1 | METHOD AND PREPARATION FOR BINDING ACETALDEHYDE IN SALIVA, THE STOMACH AND THE LARGE INTESTINE | BIOHIT OYJ (FI) | 2011-07-14 | — | — | US | claimed |
| US-20100239663-A1 | COMPOSITION FOR FOODSTUFF FOR BINDING ACETALDEHYDE | BIOHIT OYJ (FI) | 2010-09-23 | — | — | US | claimed |
| US-20100063149-A1 | FOOD COMPOSITION FOR BINDING ACETALDEHYDE IN MOUTH AND IN DIGESTIVE TRACK, AND METHOD FOR THE PREPARATION OF THE COMPOSITION | BIOHIT OYJ (FI) | 2010-03-11 | — | — | US | claimed |
| CN-101668522-A | Composition and method for binding acetaldehyde in stomach | BIOHIT OYJ | 2010-03-10 | — | — | CN | claimed |
| WO-2007135242-A1 | COMPOSITION FOR FOODSTUFF FOR BINDING ACETALDEHYDE | BIOHIT OYJ (FI) | 2007-11-29 | — | — | WO | claimed |
| WO-2007135241-A2 | COMPOSITION AND METHOD FOR BINDING ACETALDEHYDE IN STOMACH | BIOHIT OYJ (FI) | 2007-11-29 | — | — | WO | claimed |
| US-20070148215-A1 | Therapeutically active dressings, their manufacture and use | SANGUIBIOTECH GMBH (DE) | 2007-06-28 | — | — | US | claimed |
| WO-2006103316-A1 | FOOD COMPOSITION FOR BINDING ACETALDEHYDE IN MOUTH AND IN DIGESTIVE TRACK, AND METHOD FOR THE PREPARATION OF THE COMPOSITION | BIOHIT OYJ (FI) | 2006-10-05 | — | — | WO | claimed |
| WO-2006037848-A1 | METHOD AND PREPARATION FOR BINDING ALDEHYDES IN SALIVA | BIOHIT OYJ (FI) | 2006-04-13 | — | — | WO | claimed |
| US-20050267042-A1 | Method and preparation for binding acetaldehyde in saliva, stomach and large intestine | BIOHIT OYJ (FI) | 2005-12-01 | — | — | US | claimed |
| CN-1486177-A | Method and formulation for binding acetaldehyde in saliva, stomach and large intestine | ϣ�������ع�����˾ | 2004-03-31 | — | — | CN | claimed |
| EP-1339394-A1 | METHOD AND PREPARATION FOR BINDING ACETALDEHYDE IN SALIVA, STOMACH AND LARGE INTESTINE | BIOHIT OYJ (FI) | 2003-09-03 | — | — | EP | claimed |
| WO-2002036098-A1 | METHOD AND PREPARATION FOR BINDING ACETALDEHYDE IN SALIVA, STOMACH AND LARGE INTESTINE | LICENTIA LTD (FI) | 2002-05-10 | — | — | WO | claimed |
| WO-2002005785-A1 | MODULATED RELEASE THERAPEUTIC AEROSOLS | AEROPHARM TECHNOLOGY INCORPORATED (US) | 2002-01-24 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100239663-A1 | COMPOSITION FOR FOODSTUFF FOR BINDING ACETALDEHYDE | FABP2, ALDH16A1, ALDH1A1 | PTGS1 599/4885SLC7A11 84/4885GLRA1 712/4885 |
| US-20050267042-A1 | Method and preparation for binding acetaldehyde in saliva, stomach and large intestine | SI, ADH1A, ADH1C | PTGS1 1219/4885SLC7A11 738/4885GLRA1 931/4885 |
| US-20100063149-A1 | FOOD COMPOSITION FOR BINDING ACETALDEHYDE IN MOUTH AND IN DIGESTIVE TRACK, AND METHOD FOR THE PREPARATION OF THE COMPOSITION | FABP2, FABP6, ADH1A | PTGS1 1736/4885SLC7A11 1527/4885GLRA1 2405/4885 |
| US-20110171296-A1 | METHOD AND PREPARATION FOR BINDING ACETALDEHYDE IN SALIVA, THE STOMACH AND THE LARGE INTESTINE | SI, ADH1C, ADH1A | PTGS1 764/4885SLC7A11 1651/4885GLRA1 1306/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.